Singapore markets closed
  • Straits Times Index

    3,204.82
    +2.01 (+0.06%)
     
  • Nikkei

    32,402.41
    -168.62 (-0.52%)
     
  • Hang Seng

    18,057.45
    +402.04 (+2.28%)
     
  • FTSE 100

    7,726.89
    +48.27 (+0.63%)
     
  • Bitcoin USD

    26,593.39
    -149.54 (-0.56%)
     
  • CMC Crypto 200

    567.19
    -9.07 (-1.57%)
     
  • S&P 500

    4,330.00
    -72.20 (-1.64%)
     
  • Dow

    34,070.42
    -370.46 (-1.08%)
     
  • Nasdaq

    13,223.99
    -245.14 (-1.82%)
     
  • Gold

    1,945.10
    +5.50 (+0.28%)
     
  • Crude Oil

    90.66
    +1.03 (+1.15%)
     
  • 10-Yr Bond

    4.4800
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,450.23
    +2.02 (+0.14%)
     
  • Jakarta Composite Index

    7,016.84
    +25.38 (+0.36%)
     
  • PSE Index

    6,142.79
    +48.08 (+0.79%)
     

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Most smaller biotech companies would love to follow in the footsteps of Vertex Pharmaceuticals (NASDAQ: VRTX). Let's turn to a smaller biotech that Vertex knows very well: CRISPR Therapeutics (NASDAQ: CRSP). The two companies are partners in a blood disorders program and recently submitted their treatment candidate for regulatory approval.